UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051133
Receipt number R000057946
Scientific Title Verification of a co-creation project for a VR learning program on dementia and caregiving to promote preparation for the simultaneous balance of work and dementia caregiving in the working generation
Date of disclosure of the study information 2023/05/25
Last modified on 2024/05/23 09:25:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of a co-creation project for a VR learning program on dementia and caregiving to promote preparation for the simultaneous balance of work and dementia caregiving in the working generation

Acronym

Validation of co-creation project for a VR learning program on dementia and caregiving

Scientific Title

Verification of a co-creation project for a VR learning program on dementia and caregiving to promote preparation for the simultaneous balance of work and dementia caregiving in the working generation

Scientific Title:Acronym

Validation of co-creation project for a VR learning program on dementia and caregiving

Region

Japan


Condition

Condition

dementia

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to develop a learning program (content) using Virtual Reality (VR) materials on dementia and caregiving for people of working age who have no experience or are novices in dementia caregiving, in co-creation with people with dementia, family caregivers and supporters, and to evaluate and discuss the development process.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Opinions and impressions about the co-creation projects as a whole (after completion of activities)

Key secondary outcomes

Opinions, ideas, conversations, and attitudes in the co-creation project process (active)
Empowerment of family caregivers of people with dementia: Empowerment scale for family caregivers of community-dwelling people with dementia in Japan(Family caregivers only, before and after the project begins and 1-2 months after it ends)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

We will develop learning programs (content) using virtual reality (VR) materials on dementia and caregiving with people with dementia, family caregivers, and supporters, targeting working generation who have no experience or are novices in dementia caregiving.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) A person with a diagnosis or suspected diagnosis of dementia who is able to communicate and give consent and whose family caregiver agrees to participate in the study.
(2) Family caregivers of persons with dementia.
(3) Supporters who support people with dementia and their family caregivers at their place of work. (Regardless of whether or not they have obtained certification).

Key exclusion criteria

(1) Persons who are deemed unable to answer the questionnaire or interview due to difficulty in communication or significant physical or mental deterioration
(2) Those who could not give their consent.
(3) Those who have an acute illness under treatment, those who have started taking antipsychotic, anxiolytic, or antidepressant medications within 3 months, or those who have changed the type or dosage.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Sakanashi
Middle name
Last name Sayori

Organization

Fukuoka University

Division name

School of Nursing, Faculty of Medicine

Zip code

8140180

Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka-shi, Fukuoka, 814-0180 JAPAN

TEL

0928011011

Email

sakanashi@adm.fukuoka-u.ac.jp


Public contact

Name of contact person

1st name Sayori
Middle name
Last name Sakanashi

Organization

Fukuoka University

Division name

School of Nursing, Faculty of Medicine

Zip code

8140180

Address

7-45-1, Nanakuma, Jonan-ku, Fukuoka-shi, Fukuoka, 814-0180 JAPAN

TEL

0928011011

Homepage URL


Email

sakanashi@adm.fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University

Institute

Department

Personal name

Sayori Sakanashi


Funding Source

Organization

Japan Society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka University

Address

School of Nursing, Faculty of Medicine

Tel

0928011011

Email

fumed-ethics@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 05 Month 12 Day

Date of IRB

2023 Year 05 Month 15 Day

Anticipated trial start date

2023 Year 05 Month 26 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 05 Month 23 Day

Last modified on

2024 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057946